Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Marts 2023

Genmab — Marts 2023

Planlagt Fastgjort Låst Flyttet Genmab
499 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #411

    Genmab Announces Appointment of Martine van Vugt to Chief Strategy Officer https://ir.genmab.com/news-releases/news-release-details/genmab-announces-appointment-martine-van-vugt-chief-strategy

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #412

      epcoritamab on the CHMP agenda this week to discuss responses received to Day 120 List of Questions

      1 Reply Last reply
      0
      • SEACOPS Offline
        SEACOPS Offline
        SEACOP
        wrote on sidst redigeret af
        #413

        Er der nogen naturlig arvtager (kronprins/prinsesse), som blot rager lidt op?

        1 Reply Last reply
        0
        • StockBullS Offline
          StockBullS Offline
          StockBull
          wrote on sidst redigeret af
          #414

          JNJ, AbbVie,

          1 Reply Last reply
          0
          • StockBullS Offline
            StockBullS Offline
            StockBull
            wrote on sidst redigeret af
            #415

            Link Preview Image
            The M&A hunt is on — here are the prime targets

            Companies with advanced molecular therapies, oncology assets and obesity treatments could be fuel for a dealmaking fire this year.

            favicon

            PharmaVoice (www.pharmavoice.com)

            1 Reply Last reply
            0
            • B Offline
              B Offline
              bikube
              wrote on sidst redigeret af
              #416

              Sanofi proposed to acquire Provention Bio for $2,9B in cash at 273% premium.

              1 Reply Last reply
              0
              • royalR Offline
                royalR Offline
                royal
                wrote on sidst redigeret af
                #417

                Har Abbvie råd til at købe Genmab?

                1 Reply Last reply
                0
                • troldmandenT Offline
                  troldmandenT Offline
                  troldmanden
                  wrote on sidst redigeret af
                  #418

                  Tror ikke lige Amanda er så heldig med den "liste" over opkøbs kandidater. Altimmune har lige præsenteret data. Fint vægtab på ca 10%. Men "Most patients experienced nausea and vomiting of mild and moderate severity"

                  1 Reply Last reply
                  0
                  • StockBullS Offline
                    StockBullS Offline
                    StockBull
                    wrote on sidst redigeret af
                    #419

                    Ja, AbbVie (ABBV) står over for et af de stejleste patentfrafald i branchen, når Humira mister sin amerikanske eksklusivitet næste år. Analytikere forventer, at virksomheden vil have 69 milliarder dollars i frit cash flow frem til 2024 for at genopbygge sine hylder. Andre firmaer, der forventes at se høje kontanter, er Roche, Bristol Myers og Merck.

                    1 Reply Last reply
                    0
                    • S Offline
                      S Offline
                      Sukkeralf
                      wrote on sidst redigeret af
                      #420

                      Pfizer

                      1 Reply Last reply
                      0
                      • StockBullS Offline
                        StockBullS Offline
                        StockBull
                        wrote on sidst redigeret af
                        #421

                        Humira Main patent expiring: 2023

                        1 Reply Last reply
                        0
                        • StockBullS Offline
                          StockBullS Offline
                          StockBull
                          wrote on sidst redigeret af
                          #422

                          Attention Required! | Cloudflare

                          favicon

                          (www.biostock.se)

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #423

                            Daratumumab Seen as Effective in Patients With Refractory Acquired Hemophilia A https://www.rarediseaseadvisor.com/news/hem-news-briefs/daratumumab-effective-refractory-acquired-hemophilia-a-immunosuppressants-fviii/

                            1 Reply Last reply
                            0
                            • Helge_LarsenPI-redaktørH Offline
                              Helge_LarsenPI-redaktørH Offline
                              Helge_LarsenPI-redaktør
                              wrote on sidst redigeret af
                              #424

                              Godmorgen 🙂

                              1 Reply Last reply
                              0
                              • P Offline
                                P Offline
                                ProinvestorNEWS
                                wrote on sidst redigeret af
                                #425

                                March 29, 2023 : Annual General Meeting 2023 https://www.proinvestor.com/investornyt/960870/march-29-2023-annual-general-meeting-2023

                                1 Reply Last reply
                                0
                                • S Offline
                                  S Offline
                                  Stroka
                                  wrote on sidst redigeret af
                                  #426

                                  God morgen 🙂

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #427

                                    Bank of America Securities analyst Sachin Jain maintained a Buy rating on Genmab (GMAB – Research Report) yesterday and set a price target of $48.00. https://markets.businessinsider.com/news/stocks/bank-of-america-securities-reaffirms-their-buy-rating-on-genmab-gmab-1032196485

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #428

                                      AGM starting

                                      1 Reply Last reply
                                      0
                                      • DarvinD Offline
                                        DarvinD Offline
                                        Darvin
                                        wrote on sidst redigeret af
                                        #429

                                        Thank you E L BofA hits exactly what we're aiming for, so far! Converted, their target for the share price is DKK 3,002

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #430

                                          it is a bit higher isn't it? USDDKK at 6.87 gets us close to 3300?

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper